'We are hoping by March, the government allows us to export and give it to the private market.' IMAGE: A Serum Institute of India supply truck.... ...http://www.rediff.com/news/interview/coronavirus-covid-19-3-4-years-to-vaccinate-80-of-india/20210111.htm
The COVAX or COVID-19 Vaccine Global Access programme is run by Gavi, the Vaccine Alliance, and the World Health Organisation (WHO) in partnership... ...https://www.hindustantimes.com/world-news/sri-lanka-to-sign-agreement-to-secure-covid-19-vaccine-through-covax/story-QYOiXi0zSFgy2juG9CzdjI.html
As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of... ...http://www.rediff.com/news/report/speedy-vaccine-distribution-a-major-challenge-experts/20210105.htm
Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost $3-4 per shot (Rs 219-290) to the government and will be priced... ...http://www.rediff.com/news/report/covid-vaccine-to-cost-rs-290-to-govt-serum/20210104.htm
On the efficacy of Covishield, he noted that the company has proven in its trials that it has a 100 per cent efficacy on hospitalisation, implying... ...https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/coronavirus-vaccine-to-cost-3-4-to-govt-6-8-in-private-market-sii/articleshow/80097489.cms
karnataka state women's...